Annual report pursuant to Section 13 and 15(d)

17. Geographic Information

v3.8.0.1
17. Geographic Information
 12 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Geographic Information

NOTE 17 – Geographic Information

 

The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers.

 

The following table shows the Company’s product revenues by geographic region:

 

    Year Ended March 31,  
    2018     2017  
United States   $ 8,372,000     $ 6,580,000  
Latin America     3,007,000       1,299,000  
Europe and Rest of the World     4,284,000       4,078,000  
Total   $ 15,663,000     $ 11,957,000  

 

 

In connection with the Company’s sale of its Latin American business to Invekra, product revenues were reclassified from continuing operations to discontinued operations as follows:

 

    Year Ended March 31,  
    2018     2017  
Product revenues   $ –     $ 2,693,000  
Product license fees and royalties     –       412,000  
Total product related revenues   $ –     $ 3,105,000  

 

The Company’s service revenues amounted to $995,000 and $868,000 for the years ended March 31, 2018 and 2017, respectively.